Post-pandemic Era-Global Female Contraception Drug Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
MRAResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Female Contraception Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Female Contraception Drug Market by MRAResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Female Contraception Drug Market?
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
...
Major Type of Female Contraception Drug Covered in MRAResearch report
AG-890
Amphora
BAY-1007626
Drospirenone
Others
Application Segments Covered in MRAResearch Market
Clinic
Hospital
Homecare
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Female Contraception Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 AG-890 -Product Introduction and Major Manufacturers
1.1.2 Amphora -Product Introduction and Major Manufacturers
1.1.3 BAY-1007626 -Product Introduction and Major Manufacturers
1.1.4 Drospirenone -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Female Contraception Drug Status and Prospect (2015-2026)
2.1.1 China Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Female Contraception Drug Status and Prospect (2015-2026)
2.2.1 EU Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Female Contraception Drug Status and Prospect (2015-2026)
2.3.1 USA Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Female Contraception Drug Status and Prospect (2015-2026)
2.4.1 Japan Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Female Contraception Drug Status and Prospect (2015-2026)
2.5.1 India Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Female Contraception Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Female Contraception Drug Status and Prospect (2015-2026)
2.7.1 South America Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Female Contraception Drug Status and Prospect (2015-2026)
2.8.1 Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.8.2 Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Female Contraception Drug Market Assessment by Segment
3.1 Global Female Contraception Drug Capacity and Growth Rate
3.2 Global Female Contraception Drug Sales by Type
3.3 Global Female Contraception Drug Sales Revenue by Type
3.4 Global Female Contraception Drug Consumption by Application
4 Global Female Contraception Drug Market Assessment by Regions
4.1 Global Female Contraception Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Female Contraception Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Female Contraception Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Female Contraception Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Female Contraception Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Female Contraception Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Female Contraception Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Female Contraception Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Female Contraception Drug Competitive Analysis
7.1 Addex Therapeutics Ltd
7.1.1 Addex Therapeutics Ltd Company Profiles
7.1.2 Addex Therapeutics Ltd Product Introduction
7.1.3 Addex Therapeutics Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Agile Therapeutics Inc
7.2.1 Agile Therapeutics Inc Company Profiles
7.2.2 Agile Therapeutics Inc Product Introduction
7.2.3 Agile Therapeutics Inc Female Contraception Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bayer AG
7.3.1 Bayer AG Company Profiles
7.3.2 Bayer AG Product Introduction
7.3.3 Bayer AG Female Contraception Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Evofem Inc
7.4.1 Evofem Inc Company Profiles
7.4.2 Evofem Inc Product Introduction
7.4.3 Evofem Inc Female Contraception Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Hervana Ltd
7.5.1 Hervana Ltd Company Profiles
7.5.2 Hervana Ltd Product Introduction
7.5.3 Hervana Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Mithra Pharmaceuticals SA
7.6.1 Mithra Pharmaceuticals SA Company Profiles
7.6.2 Mithra Pharmaceuticals SA Product Introduction
7.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Orbis Biosciences Inc
7.7.1 Orbis Biosciences Inc Company Profiles
7.7.2 Orbis Biosciences Inc Product Introduction
7.7.3 Orbis Biosciences Inc Female Contraception Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Company Profiles
7.8.2 Teva Pharmaceutical Industries Ltd Product Introduction
7.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Viramal Ltd
7.9.1 Viramal Ltd Company Profiles
7.9.2 Viramal Ltd Product Introduction
7.9.3 Viramal Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
8 Conclusion
List of Figure
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Female Contraception Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Female Contraception Drug Sales (K Unit) by Type (2015-2026)
Figure Global Female Contraception Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Female Contraception Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Female Contraception Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Female Contraception Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Female Contraception Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Female Contraception Drug Sales (K Unit) by Application (2015-2026)
Figure China Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Female Contraception Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Female Contraception Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Female Contraception Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Female Contraception Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Female Contraception Drug Sales (Unit) by Type (2015-2026)
Figure Global Female Contraception Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Female Contraception Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Female Contraception Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Female Contraception Drug Consumption (Unit) by Application (2015-2026)
Figure Global Female Contraception Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Female Contraception Drug Production (K Unite) by Regions (2015-2020)
Table Global Female Contraception Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Female Contraception Drug Production Share by Regions (2019-2020)
Table Global Female Contraception Drug Sales (K Unite) by Regions (2015-2020)
Table Global Female Contraception Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Female Contraception Drug Sales Share by Regions (2019-2020)
Table Global Female Contraception Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Female Contraception Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Female Contraception Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Female Contraception Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Female Contraception Drug
Figure Cost Structure of Female Contraception Drug in 2020
Table Global Female Contraception Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Female Contraception Drug Capacity Share of Manufacturers (2019-2020)
Table Global Female Contraception Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Female Contraception Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Female Contraception Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Female Contraception Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Female Contraception Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ???Addex Therapeutics Ltd Profiles
Table ???Addex Therapeutics Ltd Female Contraception Drug Product Introduction
Table ???Addex Therapeutics Ltd Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ???Addex Therapeutics Ltd SWOT Analysis
Table ????Agile Therapeutics Inc Profiles
Table ????Agile Therapeutics Inc Female Contraception Drug Product Introduction
Table ????Agile Therapeutics Inc Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Agile Therapeutics Inc SWOT Analysis
Table ????Bayer AG Profiles
Table ????Bayer AG Female Contraception Drug Product Introduction
Table ????Bayer AG Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Bayer AG SWOT Analysis
Table ????Evofem Inc Profiles
Table ????Evofem Inc Female Contraception Drug Product Introduction
Table ????Evofem Inc Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Evofem Inc SWOT Analysis
Table ????Hervana Ltd Profiles
Table ????Hervana Ltd Female Contraception Drug Product Introduction
Table ????Hervana Ltd Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Hervana Ltd SWOT Analysis
Table ????Mithra Pharmaceuticals SA Profiles
Table ????Mithra Pharmaceuticals SA Female Contraception Drug Product Introduction
Table ????Mithra Pharmaceuticals SA Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Mithra Pharmaceuticals SA SWOT Analysis
Table ????Orbis Biosciences Inc Profiles
Table ????Orbis Biosciences Inc Female Contraception Drug Product Introduction
Table ????Orbis Biosciences Inc Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Orbis Biosciences Inc SWOT Analysis
Table ????Teva Pharmaceutical Industries Ltd Profiles
Table ????Teva Pharmaceutical Industries Ltd Female Contraception Drug Product Introduction
Table ????Teva Pharmaceutical Industries Ltd Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Teva Pharmaceutical Industries Ltd SWOT Analysis
Table ????Viramal Ltd Profiles
Table ????Viramal Ltd Female Contraception Drug Product Introduction
Table ????Viramal Ltd Female Contraception Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Viramal Ltd SWOT Analysis
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices